GlassScriptPhysician profile
Rajat Gupta
NPI 1225031552
$86,482.73
in general payments reported to CMS, 2019-2025
20 companies · $986 in 2025
The $986 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,472 · 2020: $27K · 2021: $31K · 2022: $19K · 2023: $1,667 · 2024: $1,163 · 2025: $986.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,471 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,470.65 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $345.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $27,962.51 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $27,884.47 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17,058.82 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $7,116.57 | 2019-2025 | Ajovy, Austedo Xr, Austedo |
| Abbvie INC. | $1,826.70 | 2021-2025 | |
| Amgen INC. | $1,095.86 | 2019-2023 | Aimovig |
| Impel Pharmaceuticals INC. | $670.48 | 2022-2023 | Trudhesa |
| Lilly USA, LLC | $663.26 | 2019-2024 | Emgality, Reyvow |
| Pfizer INC. | $651.32 | 2023-2024 | |
| Lundbeck LLC | $457.98 | 2022-2025 | Vyepti |
| Novartis Pharmaceuticals Corporation | $346.06 | 2019-2021 | |
| Tg Therapeutics, INC. | $180.36 | 2025 | |
| Tonix Medicines, INC. | $130.70 | 2024 | Zembrace Symtouch |
| Emd Serono, INC. | $100.16 | 2019 | |
| Currax Pharmaceuticals LLC | $82.89 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argenx US, INC. | $77.08 | 2022 | |
| Medtronic, INC. | $64.78 | 2023 | Intellis Adaptivestim |
| Axsome Therapeutics, INC. | $55.21 | 2025 | Symbravo |
| Upsher-Smith Laboratories LLC | $44.95 | 2020-2022 | |
| Collegium Pharmaceutical, INC. | $12.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajat Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.